Oxford Immunotec Global PLC
(NASDAQ GS: OXFD)
Rigrodsky Law, P.A. is investigating Oxford Immunotec Global PLC (“Oxford Immunotec”) regarding possible breaches of fiduciary duties and other violations of law related to Oxford Immunotec’s agreement to be acquired by PerkinElmer, Inc. Under the terms of the agreement, Oxford Immunotec’s shareholders will receive $22.00 in cash per share.